Market Samachar
CNBC
·
GLOBAL
·
Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production - CNBC
As reported by CNBC
Eli Lilly is trying to catch up in the GLP-1 pill market to Novo, which got a head start in the space.
▸ MARKET SAMACHAR VIEW
NEUTRAL
Read full article on CNBC ↗
Market Samachar is a news aggregator. This article was originally published by
CNBC. Tap the button above to read the full story on their site.
🔥 Hot Now
Top stories across markets in the last hour
-
INDIAN
Orient Cables, AceVector, German Green Steel announce IPO price bands
Share Market Today
-
INDIAN
NSE IPO: 20 investment bankers earn ₹186 crore in fees, commissions
Share Market Today
-
INDIAN
Hikal commences commercial production of personal care products
Share Market Today
-
INDIAN
Runwal Enterprises aims to boost balance sheet via ₹500 crore issue
Share Market Today
-
INDIAN
Nifty 50 deep-dive guide for investors: Bearish engulfing candlestick; check resistance, support levels | Wed 23 Sept
mint - markets
-
INDIAN
Why are foreign investors leaving Indian stocks? Bernstein flags ‘bygone’ large-cap businesses, low AI exposure
mint - markets
-
INDIAN
Why NSE IPO became India's 2nd-largest, not biggest: MD-CEO Ashishkumar Chauhan explains | Exclusive
mint - markets
-
INDIAN
Top breakout stocks to buy today: Swiggy, Welspun, Finolex, Vishal Mega Mart, Carborundum by Sumeet Bagadia | Targets
mint - markets
More from Market Samachar